Hal Barron, MD, who will become CEO and co-chair of Altos Labs. He is now GlaxoSmithKline (GSK)’s President of R&D and Chief Scientific Officer, GlaxoSmithKline (GSK) has agreed to acquire Affinivax ...
Pharmaceutical giant GlaxoSmithKline will pay a record $3 billion to settle U.S. regulators' criminal and civil fraud accusations over its marketing of two antidepressants and its reporting of a ...
Glaxosmithkline plc (GSK) pledged $2.1 billion up front and as much as $1.2 billion in development milestone payments to take over privately held Affinivax Inc. and bring aboard the phase II-stage, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results